FDA Clears Quest's Simplexa H1N1 Assay; Test Runs on New 3M Integrated Cycler

Influenza A 2009 H1N1 assay, which received the CE mark in Europe last fall, becomes the first test of its kind to receive marketing approval outside the agency's time-limited emergency-use authorization program.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.